Cardiac rehabilitation engagement and associated factors among heart failure patients: a cross-sectional study

Abstract

Background Chronic Heart Failure (CHF) still affects millions of people worldwide despite great advances in therapeutic approaches in the cardiovascular field. Cardiac rehabilitation (CR) is known to improve disease-related symptoms, quality of life and clinical outcomes, yet implementation is suboptimal, a frequently low engagement in rehabilitation programs has been found globally. Objective To quantify diverse CR-engaged processes and elucidate associated factors of the various levels of CR engagement in CHF patients. Methods Discharged patients admitted from cardiology departments between May 2022 to July 2022 were enrolled by mobile phone text messaging, CHF patients from same department between August 2022 to December 2022 were enrolled by face-to-face. Individuals who met the inclusion criteria filled the questionnaires, including the generalized anxiety disorders scale, patient health questionnaire, cardiac rehabilitation inventory, patient activation measure, Tampa scale for kinesiophobia heart, social frailty, Patient Health Engagement Scale (PHE-s®). We obtained sociodemographic characteristics and clinical data from medical records. Chi-square tests and multivariable logistic regression analyses were performed to examine the factors associated with CR engagement phases. Results A total of 684 patients were included in the study. 52.49% patients were in the Adhesion phase. At the multivariate level, compared with the blackout phase process anxiety, monthly income (RMB yuan) equal to or more than 5,000 were the most important factor impacting CHF patients CR engagement. Compared with the Blackout phase, regular exercise or not, severe depression, previous cardiac-related hospitalizations 1 or 2 times, Age influenced patient CR engagement in the Arousal phase. Besides, compared with the Blackout phase, outcome anxiety and activation level were independent factors in the Eudaimonic Project phase. Conclusion This study characterized CR engagement, and explored demographic, medical, and psychological factors—with the most important being process anxiety, monthly income, patient activation, severe depression, and previous cardiac-related hospitalizations. The associated factors of CR engagement were not identical among different phases. Our findings suggested that factors could potentially be targeted in clinical practice to identify low CR engagement patients, and strategies implemented to strengthen or overcome these associations to address low CR engagement in CHF patients.

Predictors of home-based cardiac rehabilitation exercise adherence among patients with chronic heart failure: a theory-driven cross-sectional study

“…The original scale was developed to assess exercise fear levels in patients with coronary heart disease [ 27 ]. Subsequently, this scale has been widely used in patients with chronic heart failure and proved to have good psychometric properties [ 28 , 29 ]. In this study, the Chinese version of the Tampa Scale for Kinesiophobia Heart was adopted [ 30 ].…”

Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies

“…Comprehending the genetic factors that cause heart toxicity shows potential for personalized healthcare, enabling the detection of patients with greater susceptibility and creating customized treatments [ 39 ]. Genetic testing has the potential to become a crucial part of assessing risk levels, allowing healthcare professionals to enhance cancer treatment plans while reducing the likelihood of cardiovascular issues [ 40 ].…”

“…Heightened concentrations of these biomarkers may necessitate further cardiac assessment and intervention [ 35 ]. Ongoing research is focused on incorporating new biomarkers, such as cardiac imaging-derived biomarkers or circulating microRNAs, to improve the accuracy and precision of cardiovascular monitoring in cancer patients [ 40 ].…”

Revolutionizing Cardiac Care: A Comprehensive Narrative Review of Cardiac Rehabilitation and the Evolution of Cardiovascular Medicine

“…AI-driven decision support systems help healthcare providers make data-informed choices. Pharmacogenomics considers an individual's genetic makeup when prescribing medications [26]. This approach helps identify the most effective and safest medicines for a particular patient.…”

“…Pharmacogenomic insights guide medication selection and dosing. Precision medicine ensures patients receive the most effective medications, reducing adverse effects and optimizing therapeutic outcomes [26].…”